Results
1531
Companies with a Future performance score of at least 3, ordered by Future performance score.
1,531 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ML | US$87.00 | 1.8% | 73.8% | US$986.2m | US$94.25 | PE107.7x | E75.7% | n/a | Diversified Financials | ||
CBNK | US$30.17 | -0.9% | 48.1% | US$505.2m | US$36.00 | PB1.4x | E30.2% | 1.3% | Banks | ||
LOOP | US$1.19 | -19.0% | -61.6% | US$63.3m | US$3.95 | PS449.7x | E69.5% | n/a | Materials | ||
RM | US$32.01 | -2.6% | 40.0% | US$329.8m | US$41.75 | PE7.6x | E25.6% | 3.7% | Diversified Financials | ||
PGY | US$11.60 | -14.5% | -32.4% | US$945.0m | US$21.60 | PS0.8x | E149.5% | n/a | Software | ||
CCNE | US$24.76 | -0.2% | 24.2% | US$519.0m | US$28.00 | PB0.9x | E40.5% | 2.9% | Banks | ||
CRDO | US$50.42 | -16.3% | 134.1% | US$9.2b | US$82.33 | PS34.3x | E66.2% | n/a | Semiconductors | ||
CHMI | US$3.40 | -6.6% | -4.5% | US$113.7m | US$4.00 | PB0.8x | E125.2% | 17.6% | Diversified Financials | ||
ACAD | US$18.16 | -6.8% | -23.5% | US$3.3b | US$24.75 | PE13.4x | E20.9% | n/a | Pharmaceuticals & Biotech | ||
EH | US$20.83 | -11.5% | 92.3% | US$1.5b | US$25.90 | PS27.6x | E81.1% | n/a | Capital Goods | ||
DOCN | US$40.35 | 8.6% | 4.2% | US$3.9b | US$45.46 | PE44x | E20.5% | n/a | Software | ||
WDAY | US$254.57 | -2.8% | -6.8% | US$70.0b | US$313.25 | PE128.7x | E28.1% | n/a | Software | ||
SRPT | US$101.22 | -4.1% | -18.3% | US$10.3b | US$179.91 | PE41.7x | E23.5% | n/a | Pharmaceuticals & Biotech | ||
LKNC.Y | US$27.61 | -7.9% | 30.6% | US$9.5b | US$38.84 | PE21.9x | E20.5% | n/a | Consumer Services | ||
MP | US$22.53 | -7.2% | 45.1% | US$3.9b | US$25.22 | PS18.1x | E84.0% | n/a | Materials | ||
TER | US$105.78 | -6.9% | -0.05% | US$17.8b | US$136.14 | PE31.5x | E28.4% | 0.5% | Semiconductors | ||
CVNA | US$219.45 | 1.8% | 169.1% | US$50.3b | US$274.41 | PE140.1x | E31.3% | n/a | Retail | ||
SLNO | US$45.80 | 2.1% | 0.9% | US$2.1b | US$74.29 | PB8.6x | E65.2% | n/a | Pharmaceuticals & Biotech | ||
EVOK | US$3.62 | -24.7% | -55.5% | US$7.5m | US$18.00 | PS0.9x | E124.7% | n/a | Pharmaceuticals & Biotech | ||
MOFG | US$30.52 | -0.5% | 37.9% | US$632.7m | US$36.30 | PB1.1x | E99.7% | 3.2% | Banks | ||
CBAT | US$0.82 | -3.8% | -23.6% | US$73.1m | US$2.00 | PE6.4x | E26.4% | n/a | Capital Goods | ||
RPT | US$3.28 | 3.1% | -19.0% | US$156.7m | US$4.50 | PB0.6x | E138.7% | 7.3% | Diversified Financials | ||
MC | US$68.17 | -3.2% | 30.8% | US$5.4b | US$83.43 | PE35.4x | E37.8% | 3.8% | Diversified Financials | ||
FTCI | US$2.91 | -11.6% | -42.3% | US$40.6m | US$7.60 | PS0.7x | E57.6% | n/a | Capital Goods |